Primary neonatal and pediatric ECMO transport: First experience in Spain.
| Autor: | Belda Hofheinz, Sylvia, López Fernández, Eduardo, García Torres, Enrique, Arias Dachary, Javier, Boni, Lorenzo, Tajuelo Llopis, Imanol, Orozco Gámez, Rocío, Carballo Rodríguez, Lorena, Martins Bravo, María, López Gámez, Susana, García Maellas, Maite, Gijón Mediavilla, Manuel |
|---|---|
| Předmět: |
TEAMS in the workplace
EXTRACORPOREAL membrane oxygenation T-test (Statistics) DATA analysis CATHETERIZATION MANN Whitney U Test CHI-squared test DESCRIPTIVE statistics PEDIATRICS LONGITUDINAL method REACTIVE oxygen species OXYGEN in the body RESEARCH methodology LIFE support systems in critical care STATISTICS CARDIOPULMONARY resuscitation ADVERSE health care events DATA analysis software TRANSPORTATION of patients |
| Zdroj: | Perfusion; May2024, Vol. 39 Issue 4, p797-806, 10p |
| Abstrakt: | Introduction: The organization of primary Extracorporeal membrane oxygenation (ECMO) transport is highly variable. Methods: To present the experience of the first mobile pediatric ECMO program in Spain, we designed a prospective descriptive study of all primary neonatal and pediatric (0–16 years) ECMO transports carried out over 10 years. The main variables recorded include demographic information, patient background, clinical data, ECMO indications, adverse events, and main outcomes. Results: 39 primary ECMO transports were carried out with a 66.7% survival to hospital discharge. The median age was 1.24 months[IQR: 0.09–96]. Cannulation was mostly peripheral venoarterial (33/39). The mean response time from the call from the sending center to the departure of the ECMO team was 4 h[2.2–8]. The median inotropic score at the time of cannulation was 70[17.2–206.5], with a median oxygenation index of 40.5[29–65]. In 10% of the cases, ECMO-CPR was performed. Adverse events occurred in 56.4%, mostly related to the means of transport (40% overall). On arrival at the ECMO center, 44% of the patients underwent interventions. The median PICU stay was 20.5 days[11–32]. 5 patients developed neurological sequels. Statistically significant differences between survivors and deceased patients were not found. Conclusions: A good survival rate, with a low prevalence of serious adverse events, suggests a clear benefit of primary ECMO transport when conventional therapeutic measures are exhausted and the patient is too unstable to undergo conventional transport. A nationwide primary ECMO-transport program must therefore be offered to all patients regardless of their location. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|